RxDoctor Payments Data

Boris Gershman, MD

Urology · Providence, RINPI 1013177518

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $8,276 of the $13,314 with a category attached, or 62.2%. 8 manufacturers reported payments, led by BK Medical Holding Company Inc. at 54.9% of the total. Among urology clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,314in general payments, 2019–2025

Across 21 payments — averaging $634.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • BK Medical Holding Company Inc.$7K
  • Ferring Pharmaceuticals Inc.$3K
  • Beckman Coulter, Inc.$2K
  • Photocure Inc$822
  • Urogen Pharma, Inc.$123
  • Pfizer$30
  • plus $40 from 2 others
$60,650in research payments, 2019–2025

Across 4 payments — averaging $15,163 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Photocure Inc$61K

What the payments were for

  • Consulting fees$8,27662%
  • Speaking & faculty fees$4,60035%
  • Food & beverage$4383%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
BK Medical Holding Company Inc.8$7,316
Ferring Pharmaceuticals Inc.3$2,984
Beckman Coulter, Inc.1$2,000
Photocure Inc3$822
Urogen Pharma, Inc.1$123
Pfizer2$30
Johnson & Johnson2$25
Blue Earth Diagnostics1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,314 in reported general payments places this provider in the 90th percentile of 55 urology providers in Rhode Island.

See all urology providers in Rhode Island

Medicare billing

Part B allowed, 2024
$136,250
Medicare patients
356
Services billed
982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl113$1,937
Finasteride47$635
Cefpodoxime Proxetil69$550
Levofloxacin70$112
Cephalexin40$79
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$56

Paid to pharmacies, not to this prescriber.

Other urology in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →